BusinessSanofi considers acquiring Insmed to diversify amid Dupixent patent expirationSanofi is considering acquiring Insmed Inc. to diversify its portfolio as its blockbuster drug Dupixent faces patent expiration. Insmed's strong respiratory products, like Brinsupri and Arikayce, present...Benzinga · 19 hours ago · 1 min read